Cutler Group LP Corcept Therapeutics Inc Transaction History

Cutler Group LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 04, 2022	SELL	$17.33 - $25.3 $8,665 - $12,650	-500 Closed	0 $0
Q1 2022 Apr 14, 2022	BUY	$16.53 - $25.21 $8,265 - $12,605	500 New	500 $11,000
Q1 2019 May 10, 2019	SELL	$10.03 - $15.71 $40,481 - $63,405	-4,036 Closed	0 $0
Q4 2018 Feb 05, 2019	BUY	$11.29 - $17.19 $45,566 - $69,378	4,036 New	4,036 $53,000
Q3 2018 Nov 07, 2018	SELL	$12.27 - $15.65 $503 - $641	-41 Closed	0 $0

Q1 2018 May 11, 2018	BUY	$14.59 - $25.5 $14 - $25	1 Added 2.5%	41 $0
Q4 2017 Jan 17, 2018	BUY	$15.77 - $20.72 $630 - $828	40	40 $0

314

93.8M

2.02M

3.24M

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $3.23B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.